---
$id: https://graph.org.ai/products/commodity/51281823
$type: Product
source: UNSPSC
code: "51281823"
title: "Mitoxantrone hydrochloride"
class: "51281800"
classTitle: "Anthracyclines"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mitoxantrone hydrochloride

**UNSPSC Code**: 51281823
**Class**: [Anthracyclines](Anthracyclines.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracenedione-derived antineoplastic agent, analgesic, and anthraquinone with the molecular formula C22H28N4O6.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U6USW86RD0, chemically known as 9,10-anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9ci) but more generally known as mitoxantrone hydrochloride, which bears US NIH Compound Identifier 4212. European Medicines Agency schedules Mitoxantrone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03309MIG. Most nations, for tariff and trade purposes, schedule mitoxantrone hydrochloride under HS 29225000 and SITC 51467. As of Q4 2014, MITOXANTRONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Mitoxantrone hydrochloride bears US NLM identifiers UMLS ID C1513359 and NCI Concept Code C665. SMILES: C1CC(C2C(C1NCCNCCO)C(=O)C3C(CCC(C3C2=O)O)O)NCCNCCO.CL.CL.

